Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARK Innovation ETF (ARKK)

41.05
Delayed Data
As of Jan 22
 +1.11 / +2.78%
Today’s Change
21.76
Today|||52-Week Range
41.05
+10.71%
Year-to-Date

Investment Objective

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The advisor currently intends to use only American Depositary Receipts ("ADRs") when purchasing foreign securities. The fund is non-diversified.

ALPS Launches Disruptive Technologies ETF
Jan 11 / Zacks.com - Paid Partner Content
Bitcoin: 'Red Tape', ETF Filings & Withdrawal Explained
Jan 10 / Zacks.com - Paid Partner Content

Performance

1 month+9.66% 3 years+27.38%
3 months+19.28% 5 years--
1 year+89.85% Since inception+26.18%
Data through 01/23/2018

Quote Details

Previous close$39.94
Open day’s range40.25 – 41.05
Net asset value (NAV)40.93 (01/22/2018)
Daily volume819,093
Average volume (3 months)228,666
Data as of 8:00pm ET, 01/22/2018

Peer Comparisonvs. Technology ETFs

 ARKKCategory
Performance 5-yr return--+19.49%
Expense Gross exp ratio0.75%1.40%
Risk 5 year sharpe ratio--1.35
Net assets$376.1M$1.2B
Average market cap$9.3B$41.4B
Average P/E--26.2
Dividend / Share--0.14%

Competitors

XNTK SPDR® NYSE Technology ETF
IGM iShares North American Tech ETF
XLK Technology Select Sector SPDR® Fund

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GBTC Bitcoin Investment Trust6.29%
TSLA Tesla6.13%
SSYS Stratasys Ltd4.71%
TWTR Twitter4.48%
ATHN athenahealth Inc4.39%
AMZN Amazon3.85%
ILMN Illumina Inc3.64%
NTLA Intellia Therapeutics Inc3.36%
EDIT Editas Medicine Inc2.68%
BLUE bluebird bio Inc2.10%